The global syphilis testing market is expanding as the resurgence of syphilis infections increases demand for accessible, accurate, and timely diagnostic solutions. Rising cases of syphilis among adults, growing concerns surrounding congenital syphilis, and greater emphasis on prenatal screening are encouraging healthcare systems to strengthen testing programs. At the same time, technological advances in immunoassays, molecular diagnostics, rapid testing, and decentralized screening are improving the ability to detect infections earlier. Growing awareness of sexually transmitted infections, public health initiatives, and expanded access to point-of-care testing are also shaping the market. The increasing availability of dual HIV and syphilis testing platforms is creating additional opportunities, particularly in regions where healthcare resources and laboratory infrastructure remain limited.

Track Market Growth and Metrics

The global syphilis testing market was valued at USD 1.5 billion in 2025 and is estimated to reach USD 1.6 billion in 2026. The market is projected to reach USD 2.3 billion by 2033, expanding at a CAGR of 5.2% from 2026 to 2033. North America accounted for the largest regional revenue share in 2025, while Asia Pacific is expected to register the fastest growth during the forecast period.

Key market metrics include:

• Market Size, 2025: USD 1.5 billion
• Market Estimate, 2026: USD 1.6 billion
• Projected Value, 2033: USD 2.3 billion
• Market CAGR, 2026 to 2033:2%
• Dominant Region: North America, with 36.32% revenue share in 2025
• Leading Technology: Immunoassay, with 71.2% revenue share in 2025
• Leading Testing Location: Laboratory testing, with 79.5% revenue share in 2025
• Fastest-Growing Technology: Molecular diagnostics
• Fastest-Growing Region: Asia Pacific

Download a free sample copy of the Syphilis Testing market report to understand detailed coverage and inclusions in the final report

Pinpoint Key Market Drivers

Rising Global Syphilis Prevalence: Increasing syphilis infections are creating sustained demand for screening and diagnostic testing. The continued burden of untreated infections is encouraging healthcare providers and public health agencies to expand testing programs across high-risk populations.

Growing Burden of Congenital Syphilis: Maternal syphilis remains an important public health concern because untreated infection can result in adverse pregnancy outcomes. Greater emphasis on prenatal screening and early intervention is driving demand for rapid and reliable diagnostic solutions.

Expansion of Point-of-Care Testing: Point-of-care testing is becoming increasingly important because it can provide results during a single healthcare visit. Rapid testing can reduce delays between diagnosis and treatment and can improve follow-up among patients who may face barriers to accessing centralized laboratories.

Growth of Dual HIV and Syphilis Testing: Combined testing platforms are gaining attention because they can detect multiple infections from a single sample. These solutions are particularly valuable in community health programs, prenatal screening, and resource-limited settings.

Increasing At-Home Testing: Consumer access to at-home STI testing is creating a new channel for syphilis screening. Fingerstick-based and rapid antibody tests can provide convenient initial screening while supporting earlier engagement with healthcare services.

Public Health and Elimination Programs: Government agencies and international health organizations are strengthening initiatives focused on sexually transmitted infection control and elimination of mother-to-child transmission. These programs are increasing demand for affordable, scalable, and decentralized diagnostic technologies.

Analyze Segment Metrics

The market is segmented by technology, location of testing, and region.

• By Technology: The immunoassay segment dominated the market with a 2% revenue share in 2025. Immunoassays benefit from widespread clinical adoption, established laboratory workflows, cost-effectiveness, and compatibility with high-throughput diagnostic platforms. The molecular diagnostics segment is expected to register the fastest CAGR as demand increases for highly sensitive and early infection detection.
• By Location of Testing: Laboratory testing accounted for the largest revenue share of 5% in 2025. Centralized laboratories continue to play a major role because they can support high-volume testing, automated immunoassays, confirmatory workflows, and integration with healthcare information systems. Point-of-care testing is expected to grow rapidly because of its accessibility and shorter turnaround times.
• By Laboratory Type: Commercial and private laboratories remain important testing providers because of their extensive diagnostic networks and ability to process large testing volumes. Public health laboratories also play a critical role in surveillance, disease control programs, prenatal screening, and testing among high-risk populations.

Looking for more specific insights? Customize this report to suite your business needs

Identify Major Industry Players

The syphilis testing market includes established diagnostic companies, clinical laboratory technology providers, rapid diagnostic manufacturers, and molecular testing companies. Leading companies are investing in new diagnostic technologies, rapid testing platforms, automation, multiplex testing, and decentralized solutions.

Key Industry Players

• Abbott Laboratories
• Hoffmann-La Roche Ltd.
• Bio-Rad Laboratories, Inc.
• Siemens Healthineers AG
• Danaher Corporation (Beckman Coulter)
• Thermo Fisher Scientific Inc.
• bioMérieux SA
• OraSure Technologies, Inc.
• Chembio Diagnostics, Inc.
• SD Biosensor, Inc.

Companies are focusing on product development, strategic partnerships, regulatory approvals, and expansion into emerging markets. Manufacturers are also working to improve testing accuracy, reduce turnaround times, simplify sample collection, and expand access to rapid and point-of-care diagnostic platforms.

Make informed decisions using comprehensive facility-level intelligence. Sign up @ https://www.grandviewresearch.com/horizon/hospital-database

About us:
Grand View Research, a market research and consulting company, provides syndicated research reports, customized research reports, and consulting services. Grand View Research database is used by the world's renowned academic institutions and Fortune 500 companies to understand the global and regional business environment. Our database features thousands of statistics and in-depth analysis on 46 industries in 25 major countries worldwide.